Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD

0
Vyvanse® (lisdexamfetamine dimesilate) for treatment of adults with ADHD: PBS listed from 1 February 20211,2

Early elixir: brompheniramine, a first-generation antihistamine

0
For over 70 years brompheniramine has been used to stifle sneezes … but not for everyone.

Could domestic manufacturing fix our medicine shortage problems?

0
With medicine shortages set to be an issue for the foreseeable future, local medicines manufacturing could be the way forward.

Report any CAM adverse effects, warns Dr Geraldine Moses

0
Doctor of clinical pharmacy, consultant pharmacist and pharmacovigilance expert Geraldine Moses discusses the scary adverse effects of CAM.

Antibiotic prescribing is reaching dangerous levels, warns report

0
Antibiotic use has crept back up since COVID-19 restrictions have lifted, with multi-resistant bugs increasingly in our midst.

Podcast: Migraine and the gender pain gap

0
Migraine is sometimes misunderstood as a ‘women’s disorder’, which presents barriers to diagnosis, treatment and research investment.